As shown in Figure 2, full-length betatrophin levels were higher in patients with MetS compared to those of controls with statistical significance (694.84 ± 365.51 pg/ml versus 356.64 ± 287.92 pg/ml; P < 0.001). This evidence concerns the gene ANGPTL8 and metabolic syndrome.